Skip to main content

Patient Enrollment in Cancer Treatment Trials About 7 Percent

Medically reviewed by Carmen Pope, BPharm. Last updated on April 16, 2024.

By Lori Solomon HealthDay Reporter

TUESDAY, April 16, 2024 -- Patient enrollment in cancer treatment trials is 7.1 percent, higher than historical estimates, according to a study published online April 2 in the Journal of Clinical Oncology.

Joseph M. Unger, Ph.D., from the Fred Hutchinson Cancer Center in Seattle, and colleagues provided contemporary estimates of clinical trial participation among adults with cancer. The analysis included a national sample of accreditation information submitted by the 1,200 Commission on Cancer programs, which represent ≥70 percent of all U.S. cancer cases.

The researchers found that the overall estimated patient participation rate in cancer treatment trials was 7.1 percent. Participation was also seen in a wide variety of other studies, including biorepository (12.9 percent), registry (7.3 percent), genetic (3.6 percent), quality-of-life (2.8 percent), diagnostic (2.5 percent), and economic (2.4 percent) studies. For treatment trials, enrollment occurred in National Cancer Institute-designated comprehensive cancer centers (21.6 percent), academic (non–National Cancer Institute-designated) comprehensive cancer programs (5.4 percent), integrated network cancer programs (5.7 percent), and community programs (4.1 percent). Just over one in five patients participated in one or more cancer clinical research studies (21.9 percent).

"Contributions of adult patients with cancer to clinical research is more common than previously understood," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

American College of Surgeons, Oct. 19-22

The annual meeting of the American College of Surgeons was held this year from Oct. 19 to 22 in San Francisco and attracted participants from around the world, including...

Restaging MRI Can Predict Survival With Rectal Cancer

TUESDAY, Oct. 29, 2024 -- Restaging magnetic resonance imaging (MRI) can predict organ preservation and survival with rectal cancer, according to a study published online...

ACS: Many Cancer Patients Face Lasting Financial Difficulties

MONDAY, Oct. 28, 2024 -- Many patients with cancer diagnoses experience lasting financial difficulties, according to two studies presented at the annual meeting of the American...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.